SCHEMBL23965380

SCHEMBL23965380

c1ccc2c(c1)Oc1ccccc1C21c2ccccc2-c2c(-c3nc(-c4ccc5ccccc5c4)nc(-c4cccc5c4-c4ccccc4C54c5ccccc5Oc5ccccc54)n3)cccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.34
HDAC4 P56524 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP1A2 P05177 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
TSHR P16473 1/20 0.32
KLF5 Q13887 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GSTP1 P09211 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21658365 1.00 KDM4E (0.34) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL21658350 0.96 KDM4E (0.39) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL21658351 0.95 KDM4E (0.38) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL23965054 0.95 KDM4E (0.38) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL23965144 0.94 KDM4E (0.37) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL23965279 0.94 KDM4E (0.34) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL21658367 0.94 CYP1A2 (0.35) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL23965274 0.93 KDM4E (0.36) KDM4EMAPK1ATMSMN1; SMN2ALDH1A1
SCHEMBL22908030 0.93 KDM4E (0.38) KDM4EMAPK1ATMHDAC4HDAC2
SCHEMBL31068386 0.93 KDM4E (0.38) KDM4EMAPK1ATMHDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 KDM4E 2468/4885MAPK1 1604/4885ATM 1718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.